Engineering the Future of Biology

​Biology is producing breakthroughs faster than ever. The bottleneck isn't discovery anymore - it's everything that happens after: getting a molecule, a model, or a platform out of the lab and into the world.

​As part of Deeptech Week Israel, Grove Ventures partners with Arc, Shiba's innovation arm, for an evening on closing that gap.

​Renana Ashkenazi (Managing Partner, Grove Ventures) opens with her POV on where biotech is genuinely stuck today, where the opportunity is biggest, and how AI is starting to compress the distance between discovery and deployment, turning years-long validation cycles into something startups can actually move through.

​Arc takes the stage next to unpack how they operate as a design partner, not just an investor, what it actually looks like to build alongside a startup, help it scale, and open the door to global markets from day one.

​The evening closes with a panel of industry leaders getting candid about what's really working in biotech right now, what isn't, and how founders and investors can stay on the right path as the field moves fast in every direction.

​Join us for the conversation.